High drug costs create issues related to access and justice for pediatric patients. Advances in biotechnology make it likely that high drug costs will increasingly impact the ability to provide the “best” care for children.John Lantos, MD, FAAP, discusses the ethical tension created when patients may benefit from an expensive medication but at great cost to society.